Clinical Trial

Resistant Starch Blend Gastrointestinal Impact

Study Description

Resistant Starch Blend Gastrointestinal Impact

This study aims to test the hypothesis that a unique blend of resistant starches and fiber will promote gastrointestinal health, as measured by an increase in short-chain fatty acids and improvement in quality of life measures in conjunction with microbial community changes. This study specifically evaluates the impact on short-chain fatty acids and gut microbiota and the impact on quality of life from a resistant starch blend in healthy adult humans with occasional gastrointestinal distress.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Supplement - RS blend

The intervention is a proprietary resistant starch blend.

Placebo

The placebo is starch.

Additional Information

Official Study Title

A Pilot Study to Evaluate the Gastrointestinal Response to Increasing Doses of a Resistant Starch Blend in Healthy Subjects

Clinical Trial ID

NCT03983772

ParticipAid ID

dNk6ve